LEADER 00000cam 2200661Ii 4500
001 ocn904437712
003 OCoLC
005 20151118131304.0
006 m o d
007 cr cnu---unuuu
008 150306s2015 sz a ob 001 0 eng d
019 908097412
020 9783319121666|q(electronic bk.)
020 3319121669|q(electronic bk.)
024 7 10.1007/978-3-319-12166-6|2doi
035 (OCoLC)904437712|z(OCoLC)908097412
040 N$T|beng|erda|epn|cN$T|dN$T|dGW5XE|dE7B|dIDEBK|dUPM|dCOO
|dYDXCP|dEBLCP|dDEBSZ|dSTJ
049 STJJ
050 4 RC280.L5
072 7 HEA|x039000|2bisacsh
072 7 MED|x014000|2bisacsh
072 7 MED|x022000|2bisacsh
072 7 MED|x112000|2bisacsh
072 7 MED|x045000|2bisacsh
082 04 616.99436|223
099 PHARM WORLD WIDE WEB|aE-BOOK|aSPRINGER
245 03 An information technology framework for predictive,
preventive and personalised medicine :|ba use-case with
hepatocellular carcinoma /|cLeonard Berliner, Heinz U.
Lemke, editors.
264 1 Cham ;|aHeidelberg ;|aNew York :|bSpringer,|c[2015]
264 4 |c©2015
300 1 online resource :|billustrations.
336 text|btxt|2rdacontent
337 computer|bc|2rdamedia
338 online resource|bcr|2rdacarrier
490 1 Advances in predictive, preventive and personalised
medicine ;|vvolume 8
504 Includes bibliographical references and indexes.
505 0 Preface -- Introduction -- The Digital Patient Model and
Model Guided Therapy -- Hepatocellular Carcinoma and
Patient Assessment -- Imaging in Hepatocellular Carcinoma:
Radiologic Assessment -- Imaging in Hepatocellular
Carcinoma: PET/CT -- Personalized Chemotherapy for
Hepatocellular Carcinoma -- Surgical Treatment for
Hepatocellular Carcinoma -- Minimally Invasive Therapies
for Hepatocellular Cancer: Ablation Technologies --
Minimally Invasive Therapies for Hepatocellular Cancer:
Ablation Therapies -- Minimally Invasive Therapies for
Hepatocellular Cancer: Catheter-Directed Therapies --
Radiation Oncology in the Treatment of Hepatocellular
Carcinoma -- Design of an IT System for Hepatocellular
Carcinoma -- Outlook and Expert Recommendations for
Predictive, Preventive and Personalized Medicine and
Hepatocellular Carcinoma.
520 This book explores how PPPM, clinical practice, and basic
research could be best served by information technology
(IT). A use-case was developed for hepatocellular
carcinoma (HCC). The subject was approached with four
interrelated tasks: (1) review of clinical practices
relating to HCC; (2) propose an IT system relating to HCC,
including clinical decision support and research needs;
(3) determine how a clinical liver cancer center can
contribute; and, (4) examine the enhancements and impact
that the first three tasks will have on the management of
HCC. An IT System for Personalized Medicine (ITS-PM) for
HCC will provide the means to identify and determine the
relative value of the wide number of variables, including
clinical assessment of the patient -- functional status,
liver function, degree of cirrhosis, and comorbidities;
tumor biology, at a molecular, genetic and anatomic level;
tumor burden and individual patient response; medical and
operative treatments and their outcomes.
588 0 Vendor-supplied metadata.
650 0 Liver|xCancer|xInformation technology.
650 0 Medicine, Preventive.
650 0 Precision medicine.
650 0 Liver|xCancer|xTreatment.
650 0 Liver|xCancer.
650 0 Oncology.
650 7 HEALTH & FITNESS / Diseases / General.|2bisacsh
650 7 MEDICAL / Clinical Medicine.|2bisacsh
650 7 MEDICAL / Diseases.|2bisacsh
650 7 MEDICAL / Evidence-Based Medicine.|2bisacsh
650 7 MEDICAL / Internal Medicine.|2bisacsh
655 0 Electronic books.
700 1 Berliner, Leonard,|eeditor.
700 1 Lemke, H. U.|q(Heinz U.),|eeditor.
776 08 |iPrinted edition:|z9783319121659
830 0 Advances in predictive, preventive and personalised
medicine ;|vvolume 8.
994 02|bSTJ
